Advertisement

Topics

Kite Announces Pricing of Public Offering of Common Stock

09:23 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Kite Pharma, Inc. (Nasdaq:KITE) today announced the pricing of its previously announced underwritten public offering of 4,750,000 shares of its common stock at a price to the public of $75.00 per share. The offering is expected...

Other Sources for this Article

Kite Pharma, Inc.
Christine Cassiano
SVP, Corporate Communications & Investor Relations
ccassiano@kitepharma.com
or
Greg Mann
VP, Investor Relations
gmann@kitepharma.com

NEXT ARTICLE

More From BioPortfolio on "Kite Announces Pricing of Public Offering of Common Stock"

Advertisement
Quick Search
Advertisement
Advertisement